Menu

Blog

Mar 9, 2024

Remission from B-Cell ALL with Chemo-Free Induction Therapy

Posted by in category: biotech/medical

Durable remission was achieved with front-line dasatinib plus blinatumomab in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia.


NEJM Journal Watch reviews over 250 scientific and medical journals to present important clinical research findings and insightful commentary.

Comments are closed.